William J Moss1, John Pang1, Ryan K Orosco1, Philip A Weissbrod1, Kevin T Brumund1,2, Robert A Weisman1, Matthew T Brigger1,3, Charles S Coffey1,2. 1. Department of Surgery, division of Otolaryngology-Head & Neck Surgery, University of California, San Diego, California, U.S.A. 2. Department of Surgery, division of Otolaryngology-Head & Neck Surgery, VA San Diego Healthcare, La Jolla, California, U.S.A. 3. Department of Otolaryngology-Head & Neck Surgery, Naval Medical Center San Diego, San Diego, California, U.S.A.
Abstract
OBJECTIVE: To characterize the safety profile and effectiveness of esophageal dilation in head and neck cancer patients. METHODS: A systematic review was undertaken for articles reporting outcomes of esophageal dilation in head and neck cancer patients. The Medline, Scopus, Web of Science, and Cochrane databases were searched in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Complications related to esophageal dilation in head and neck cancer patients was the primary outcome of interest. Success rates, demographic data, cancer staging, and treatment data were assessed secondarily. Statistical analyses included both qualitative and quantitative assessments. A limited meta-analysis and pooling of the data was performed using a random effects model. RESULTS: Of the collective 8,243 initial candidate articles, 15 retrospective studies containing data for a collective 449 patients were ultimately included in the analysis. There was significant heterogeneity in the outcomes data. With an overall complication rate of 10.6% (95% confidence interval [CI]: 4.1%,17%) and a pooled success rate of 72.9% (95% CI: 65.7%,80.1%) per patient, the articles generally supported the use of dilation. CONCLUSION: Head and neck cancer patients experience a higher rate of complications following dilation compared to patients with other causes of benign stricture. Esophageal dilation is effective in improving dysphagia, but these benefits are often transient and thus necessitate repeat interventions. Laryngoscope, 128:111-117, 2018.
OBJECTIVE: To characterize the safety profile and effectiveness of esophageal dilation in head and neck cancerpatients. METHODS: A systematic review was undertaken for articles reporting outcomes of esophageal dilation in head and neck cancerpatients. The Medline, Scopus, Web of Science, and Cochrane databases were searched in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Complications related to esophageal dilation in head and neck cancerpatients was the primary outcome of interest. Success rates, demographic data, cancer staging, and treatment data were assessed secondarily. Statistical analyses included both qualitative and quantitative assessments. A limited meta-analysis and pooling of the data was performed using a random effects model. RESULTS: Of the collective 8,243 initial candidate articles, 15 retrospective studies containing data for a collective 449 patients were ultimately included in the analysis. There was significant heterogeneity in the outcomes data. With an overall complication rate of 10.6% (95% confidence interval [CI]: 4.1%,17%) and a pooled success rate of 72.9% (95% CI: 65.7%,80.1%) per patient, the articles generally supported the use of dilation. CONCLUSION: Head and neck cancerpatients experience a higher rate of complications following dilation compared to patients with other causes of benign stricture. Esophageal dilation is effective in improving dysphagia, but these benefits are often transient and thus necessitate repeat interventions. Laryngoscope, 128:111-117, 2018.
Authors: Laura W J Baijens; Margaret Walshe; Leena-Maija Aaltonen; Christoph Arens; Reinie Cordier; Patrick Cras; Lise Crevier-Buchman; Chris Curtis; Wojciech Golusinski; Roganie Govender; Jesper Grau Eriksen; Kevin Hansen; Kate Heathcote; Markus M Hess; Sefik Hosal; Jens Peter Klussmann; C René Leemans; Denise MacCarthy; Beatrice Manduchi; Jean-Paul Marie; Reza Nouraei; Claire Parkes; Christina Pflug; Walmari Pilz; Julie Regan; Nathalie Rommel; Antonio Schindler; Annemie M W J Schols; Renee Speyer; Giovanni Succo; Irene Wessel; Anna C H Willemsen; Taner Yilmaz; Pere Clavé Journal: Eur Arch Otorhinolaryngol Date: 2020-12-19 Impact factor: 2.503
Authors: Patrick L Stoner; Amy L Fullerton; Alyssa M Freeman; Neil N Chheda; David S Estores Journal: Gastroenterol Res Pract Date: 2019-05-28 Impact factor: 2.260
Authors: Anouk S Schimberg; David J Wellenstein; Henrieke W Schutte; J Honings; Henri A M Marres; Robert P Takes; Guido B van den Broek Journal: Dysphagia Date: 2021-03-10 Impact factor: 3.438